close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Home・Aandelen Lijst・Lyell Immunopharma Inc
Search

Lyell Immunopharma Inc

Gesloten

22.71 0.75

Neutraal

Prijsupdate 6 feb 2026, 20:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

22.22

Max

22.93

Belangrijke statistieken

By Trading Economics

Inkomsten

3.8M

-39M

Verkoop

7K

15K

EPS

-2.13

Winstmarge

-258,973.333

Werknemers

300

EBITDA

6.3M

-36M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+25.88% upside

Dividenden

By Dow Jones

Volgende Winsten

9 mrt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

187M

526M

Vorige openingsprijs

21.96

Vorige sluitingsprijs

22.71

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

0.4217 / 0.4691 Steun & Weerstand

Lyell Immunopharma Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 feb 2026, 09:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

DJ

Lezen

7 feb 2026, 09:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

7 feb 2026, 05:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

DJ

Lezen

7 feb 2026, 02:46 UTC

Acquisities, Fusies, Overnames

Big Money, High Anxiety -- Barrons.com

DJ

Lezen

6 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

6 feb 2026, 21:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

DJ

Lezen

6 feb 2026, 21:40 UTC

Acquisities, Fusies, Overnames

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

DJ

Lezen

6 feb 2026, 21:22 UTC

Marktinformatie

Mexico's Inflation Seen Accelerating in January -- Market Talk

DJ

Lezen

6 feb 2026, 21:17 UTC

Winsten

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

DJ

Lezen

6 feb 2026, 21:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

DJ

Lezen

6 feb 2026, 21:14 UTC

Acquisities, Fusies, Overnames

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

DJ

Lezen

6 feb 2026, 21:13 UTC

Winsten

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

DJ

Lezen

6 feb 2026, 21:13 UTC

Winsten

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

DJ

Lezen

6 feb 2026, 21:04 UTC

Marktinformatie

Gold Closes Out Volatile Week on Higher Note -- Market Talk

DJ

Lezen

6 feb 2026, 20:34 UTC

Winsten

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

DJ

Lezen

6 feb 2026, 20:27 UTC

Winsten

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More -- Barrons.com

DJ

Lezen

6 feb 2026, 20:24 UTC

Marktinformatie

Oil Futures Settle Higher As U.S.-Iran Talks Get Under Way -- Market Talk

DJ

Lezen

6 feb 2026, 20:20 UTC

Marktinformatie

U.S. Natural Gas Futures Retreat Ahead of Weekend -- Market Talk

DJ

Lezen

6 feb 2026, 19:48 UTC

Winsten

Take-Two, Mondelez Get Analyst Attention -- Barrons.com

DJ

Lezen

6 feb 2026, 19:30 UTC

Acquisities, Fusies, Overnames

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- WSJ

DJ

Lezen

6 feb 2026, 19:30 UTC

Acquisities, Fusies, Overnames

Justice Department Asking Industry How Netflix or Paramount Deal for Warner Bros. Might Impact Competition, According to Subpoena -- WSJ

DJ

Lezen

6 feb 2026, 19:30 UTC

Acquisities, Fusies, Overnames

DOJ Asking if Netflix Engaged in 'Exclusionary Conduct' That May Lead to Monopoly, According to Subpoena -- WSJ

DJ

Lezen

6 feb 2026, 19:17 UTC

Marktinformatie

USDA Says Farm Income to Decrease in 2026 -- Market Talk

DJ

Lezen

6 feb 2026, 18:50 UTC

Winsten

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

DJ

Lezen

6 feb 2026, 18:47 UTC

Marktinformatie

Natural Gas-Infrastructure Operators Take 'Flight to Scale' -- Market Talk

DJ

Lezen

6 feb 2026, 18:34 UTC

Marktinformatie

U.S. Oil Rig Count Rises By 1 to 412 -- Market Talk

DJ

Lezen

6 feb 2026, 17:58 UTC

Winsten

Reddit Stock Falls After Strong Earnings. Wall Street Is Debating What's Next. -- Barrons.com

DJ

Lezen

6 feb 2026, 17:52 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

DJ

Lezen

6 feb 2026, 17:52 UTC

Marktinformatie
Winsten

Amazon's CapEx Seen as Misunderstood by Investors -- Market Talk

DJ

Lezen

6 feb 2026, 17:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

Lyell Immunopharma Inc Prognose

Koersdoel

By TipRanks

25.88% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 28.5 USD  25.88%

Hoogste 45 USD

Laagste 12 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Lyell Immunopharma Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

2 ratings

1

Buy

0

Hold

1

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Lyell Immunopharma Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

0.4217 / 0.4691Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Weak Bearish Evidence

There is one bearish event.

Lange Termijn

No Evidence

There are no events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

JNJ

Johnson and Johnson

240

↑ +0.98%

UNH

UnitedHealth Group Inc

276.41

↑ +2.98%

TMO

Thermo Fisher Scientific Inc

542.03

↑ +0.18%

ABT

Abbott Laboratories

110.82

↑ +1.61%

ISRG

Intuitive Surgical Inc

487.26

↑ +2.36%
help-icon Live chat